Tag

Treatment Guidelines

All articles tagged with #treatment guidelines

health1 year ago

"NIH Ceases COVID Treatment Guidelines"

The National Institutes of Health (NIH) has ended its influential COVID-19 Treatment Guidelines, marking a milestone in the pandemic. The availability of COVID-19 treatments has evolved over the past four years, with Pfizer's Paxlovid and Merck's molnupiravir being authorized as outpatient treatments. However, low usage rates and challenges in prescribing these drugs persist, contributing to underuse of effective treatments. Moving forward, specialty doctors groups will take over the responsibility of providing COVID-19 treatment guidance, as the evolution of treatments offers valuable lessons for dealing with new emerging infectious diseases.

health-and-wellness1 year ago

"Exercise as Effective as Therapy for Treating Depression, Global Study Finds"

A global study published in the British Medical Journal suggests that exercise is an effective treatment for depression, regardless of comorbidities or baseline depression levels. The study found that various exercise modalities, including walking or jogging, yoga, and strength training, were well-tolerated and effective in reducing depression. The researchers recommend including exercise as part of clinical practice guidelines for depression, particularly vigorous intensity exercise, to increase treatment options and reduce stigma associated with seeking treatment for depression.

health2 years ago

"WHO's Updated COVID Treatment Guidelines: Reducing Hospitalizations and Anticipating Future Surges"

The World Health Organization (WHO) has updated its guidelines for COVID-19 therapeutics, providing revised recommendations for patients with non-severe COVID-19. The update includes updated risk rates for hospital admission in patients with non-severe COVID-19, categorizing individuals into high, moderate, or low risk. WHO strongly recommends nirmatrelvir-ritonavir (Paxlovid) for high-risk and moderate-risk patients, with molnupiravir or remdesivir as alternatives if nirmatrelvir-ritonavir is unavailable. The use of ivermectin for non-severe COVID-19 is strongly advised against, while its use in severe or critical cases is limited to clinical trials.

health2 years ago

Cracking the Code: Unraveling the Enigma of Sleep Disorders

Arousal disorders, such as sexsomnia, sleepwalking, and sleep terrors, lack established treatment guidelines unlike other sleep disorders. A study suggests that cognitive behavioral therapy, hypnosis, sleep hygiene, and scheduled awakenings may be effective treatments. These disorders can be dangerous and result in injuries, and patients often have no memory of their actions during episodes. Randomized controlled trials are needed to determine the efficacy of behavioral treatments for arousal disorders.

health2 years ago

Rethinking Back Pain Treatment: Opioids Not the Solution, New Study Finds

A world-first trial led by the University of Sydney has found that opioids are not more effective than a placebo for treating acute back and neck pain and may even pose a risk for harm. The researchers argue that treatment guidelines should be updated to advise against using opioids for this type of pain. The study highlights the need to reassess the use of opioid pain-relieving medicines due to limited evidence of benefit and known significant risk of harm. Reducing the overuse of opioids is a global health priority, and medical authorities are shifting focus to non-opioid treatments for low back pain.